News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
OBS Medical Announces FDA Clearance of New Patient Safety Technology
October 1, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
INDIANAPOLIS--(BUSINESS WIRE)--OBS Medical announced today that the Food and Drug Administration has granted 510(k) clearance for the company to market its next generation patient deterioration early warning system (VisensiaTM) in the United States.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
MORE ON THIS TOPIC
Regulatory
Acting CBER, CDER heads become permanent as FDA works to restore stability
September 9, 2026
·
2 min read
·
Tristan Manalac
Approvals
AstraZeneca’s SERD pill overcomes adcomm defeat to win FDA nod in breast cancer
September 8, 2026
·
2 min read
·
Tristan Manalac
Approvals
FDA approves Ionis’ antisense drug as first targeted therapy for Alexander disease
September 3, 2026
·
5 min read
·
Heather McKenzie
FDA
Replimune’s melanoma drug would have been rejected again if not for senior CBER official
September 3, 2026
·
2 min read
·
Tristan Manalac